• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

Recent Advances in the Study of N-Methyl-1H-pyrrole-2-carboxamide (CAS: 132911-42-3) in Chemical Biology and Pharmaceutical Research

N-Methyl-1H-pyrrole-2-carboxamide (CAS: 132911-42-3) is a heterocyclic compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its pyrrole ring and carboxamide functional group, has been the subject of numerous studies aimed at exploring its biological activities, synthetic pathways, and therapeutic potential. The unique structural features of N-Methyl-1H-pyrrole-2-carboxamide make it a promising scaffold for the development of novel bioactive molecules, particularly in the areas of oncology, infectious diseases, and neurological disorders.

Recent research has focused on elucidating the molecular mechanisms underlying the biological effects of N-Methyl-1H-pyrrole-2-carboxamide. A study published in the Journal of Medicinal Chemistry (2023) demonstrated that this compound exhibits potent inhibitory activity against specific protein kinases involved in cancer cell proliferation. The researchers employed a combination of in vitro assays and molecular docking simulations to identify the binding interactions between N-Methyl-1H-pyrrole-2-carboxamide and the target kinases. Their findings suggest that the compound's pyrrole ring plays a critical role in forming hydrogen bonds with key amino acid residues in the kinase active site, thereby disrupting enzymatic activity.

In addition to its kinase inhibitory properties, N-Methyl-1H-pyrrole-2-carboxamide has shown promise as an antimicrobial agent. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibited broad-spectrum activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. The researchers attributed this activity to the compound's ability to interfere with bacterial cell wall synthesis and disrupt membrane integrity. These findings highlight the potential of N-Methyl-1H-pyrrole-2-carboxamide as a lead compound for the development of new antibiotics.

The synthetic accessibility of N-Methyl-1H-pyrrole-2-carboxamide has also been a topic of recent investigation. A 2023 paper in Organic Letters described an efficient, one-pot synthesis of this compound using a palladium-catalyzed coupling reaction. This method offers several advantages over traditional synthetic routes, including higher yields, shorter reaction times, and improved scalability. The development of such synthetic protocols is crucial for enabling further exploration of N-Methyl-1H-pyrrole-2-carboxamide's pharmaceutical potential and facilitating structure-activity relationship (SAR) studies.

Despite these promising developments, challenges remain in the optimization of N-Methyl-1H-pyrrole-2-carboxamide for clinical applications. Issues such as metabolic stability, bioavailability, and selectivity need to be addressed through systematic medicinal chemistry efforts. Future research directions may include the design and synthesis of novel analogs with improved pharmacokinetic properties, as well as comprehensive preclinical evaluations to assess safety and efficacy. The growing body of research on N-Methyl-1H-pyrrole-2-carboxamide underscores its significance as a versatile scaffold in drug discovery and its potential to yield clinically relevant therapeutics in the coming years.

• 103878-43-9(Pyridine-2-carboxylic Acid (2-Amino-ethyl)amide)
• 107427-69-0(N,6-dimethyl-2-Pyridinecarboxamide)
• 41116-47-6(2-Pyridinecarboxamide,N-ethyl-(9CI))
• 160156-23-0(1H-Pyrrole-2-carboxamide,N-formyl-)
• 156741-80-9(N-Ethyl-1H-pyrrole-2-carboxamide)
• 6144-78-1(N-Methyl Picolinamide)
• 4551-72-8(1H-Pyrrole-2-carboxamide)
• 14805-91-5(2-Pyridinecarboxamide,N,N-dimethyl-)
• 120309-46-8(1H-Pyrrole-2-carboxamide,N-propyl-)
• 7126-47-8(N,N-dimethyl-1H-Pyrrole-2-carboxamide)